News Sentiment

ORGO sentiment intelligence

Organogenesis Holdings Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 45 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 2.40 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 45

directly relevant articles

Source quality 5

high-authority source matches

Trend context Trend inactive

+1.7% over one week, +2.6% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026

Market Reaction

Balanced read

60/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction 1.7% Price digesting
Trend fit Trend inactive 2.6% over four weeks
Fair value -30.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 32
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 45
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 16
GlobeNewswire 4
TradingView 4
Seeking Alpha 4
Investing.com 3
Market source 2
simplywall.st 2
Ad-hoc-news.de 1

Event Lens

What the news is about

Classified themes
Market update 27
Earnings 14
Deals and strategy 2
Analyst action 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-45 of 45
marketscreener.com Direct company coverage

Organogenesis Cleared to Begin Rolling BLA for ReNu Knee Osteoarthritis Therapy

Organogenesis has received clearance to initiate a rolling Biologics License Application (BLA) for its ReNu therapy, designed to treat knee osteoarthritis. This announcement follows a successful meeting with the FDA, and the company plans to submit the BLA for their ReNu product,

Tone
Neutral 50/100
Event
Market update
Published
06 Apr 2026 17:59
Source
marketscreener.com
Stock Titan Direct company coverage

Organogenesis to discuss Q1 results and corporate update May 7

Organogenesis Holdings Inc. (Nasdaq: ORGO) will report its first-quarter fiscal year 2026 financial results after market close on May 7, 2026. The company will host a conference call and live webcast at 5:00 p.m. Eastern Time on the same day to discuss the results and provide a c

Tone
Neutral 50/100
Event
Earnings
Published
06 Apr 2026 16:10
Source
Stock Titan
Stock Titan Direct company coverage

Director at Organogenesis (NASDAQ: ORGO) purchases 5,000 shares

Organogenesis Holdings Inc. director Arthur S. Leibowitz reported an open-market purchase of 5,000 shares of Class A common stock at $2.681 per share on March 9, 2026. This transaction increased his directly held stake to 291,014 shares. The purchase, detailed in an SEC Form 4 fi

Tone
Positive 71/100
Event
Deals and strategy
Published
12 Mar 2026 21:09
Source
Stock Titan
Stock Titan Direct company coverage

Organogenesis (ORGO) director adds 10,000 shares in open-market purchase

Organogenesis Holdings Inc. director Michael Joseph Driscoll purchased 10,000 shares of Class A Common Stock in an open-market transaction on March 9, 2026. He bought the shares at approximately $2.67 per share, totaling around $26,688. This purchase increases his direct ownershi

Tone
Positive 69/100
Event
Market update
Published
12 Mar 2026 08:40
Source
Stock Titan
Investing.com Direct company coverage

Organogenesis director Leibowitz buys $13k in ORGO stock

Arthur S. Leibowitz, a director at Organogenesis Holdings Inc (NASDAQ:ORGO), purchased 5,000 shares of Class A Common Stock for $13,405. This insider buying occurred as ORGO stock trades near its 52-week low, and an InvestingPro analysis suggests the stock is undervalued and in o

Tone
Neutral 50/100
Event
Market update
Published
12 Mar 2026 07:53
Source
Investing.com
Stock Titan Direct company coverage

Organogenesis (ORGO) VP uses 700 shares to cover tax withholding

Organogenesis Holdings Inc.'s VP of Strategy, Robert Cavorsi, reported a tax-related transfer of 700 Class A common stock shares at $3.21 each to cover tax withholding obligations. This transaction leaves him with 275,524 direct shares. This was not a traditional buy or sell but

Tone
Neutral 50/100
Event
Market update
Published
07 Mar 2026 07:52
Source
Stock Titan
Stock Titan Direct company coverage

[Form 4/A] Organogenesis Holdings Inc. Amended Insider Trading Activity

This article reports on an amended insider trading activity for Organogenesis Holdings Inc. (ORGO). The company's Chief Financial Officer, Francisco David, filed an amended Form 4 correcting the share counts for an equity award vesting and related tax withholding, which occurred

Tone
Neutral 50/100
Event
Market update
Published
05 Mar 2026 12:09
Source
Stock Titan
Stock Titan Direct company coverage

Organogenesis (NASDAQ: ORGO) officer amends Form 4 for award and tax-withheld shares

Organogenesis Holdings Inc. Chief Administrative and Legal Officer, Lori Freedman, filed an amended Form 4 to correct previously reported figures regarding her insider holdings. The amendment clarifies that she acquired 43,212 shares of Class A common stock from a performance sha

Tone
Neutral 50/100
Event
Market update
Published
03 Mar 2026 21:51
Source
Stock Titan
Stock Titan Direct company coverage

Organogenesis (ORGO) VP updates Form 4 for award vesting and tax shares

Organogenesis Holdings Inc.'s VP of Strategy, Robert Cavorsi, filed an amended Form 4 to correct details regarding a performance share award. The filing clarifies the number of Class A Common Stock shares acquired upon vesting (16,454) and shares withheld for tax obligations (5,4

Tone
Neutral 50/100
Event
Market update
Published
03 Mar 2026 21:51
Source
Stock Titan